Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Intellego Technologies AB (publ) (“Intellego” or the “Company”) today announces the outcome of the exercise of warrants of series TO 2024/2026 (the “Warrants”), which were issued in September 2024. The Warrants were issued to a limited group of professional and private investors. All 616,572 Warrants were exercised, resulting in the subscription of 616,572 shares. Each Warrant entitled the holder to subscribe for one new share in the Company at a price of SEK 36.96 per share. Through the exercise of the Warrants, Intellego receives approximately SEK 22.8 million before issuing costs.
Background
As of September 19, 2024, the Board of Directors, with the support of the authorization from the Annual General Meeting 2024, decided to carry out a directed issue of units (shares and warrants of series TO 2024/2026) to a limited number of professional and private investors. A total of 616,572 Warrants has been exercised for the subscription of a total of 616,572 shares in Intellego. Each warrant entitled the holder to subscribe for one (1) share at a price of SEK 36.96 per share during the period from September 19, 2025, to September 29, 2026. Through the exercise of the Warrants, Intellego receives approximately SEK 22.8 million before issuing costs. The original press release regarding the issuance of Warrants is available by clicking here.
Number of shares, share capital and dilution
Through the exercise of the Warrants the number of shares in Intellego increases by a total of 616,572 shares, from 30,740,395 shares to 31,356,967 shares and the share capital increases by approximately SEK 22,020.43, from approximately SEK 1,097,871.26 to approximately SEK 1,119,891.69. The exercise of the Warrants entails a dilution of approximately 1.97 percent of the total number of shares and votes.